A detailed history of Us Bancorp \De\ transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 26,579 shares of VRTX stock, worth $13.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,579
Previous 24,306 9.35%
Holding current value
$13.7 Million
Previous $11.4 Million 8.51%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$460.0 - $505.78 $1.05 Million - $1.15 Million
2,273 Added 9.35%
26,579 $12.4 Million
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $1.12 Million - $1.39 Million
2,856 Added 13.31%
24,306 $11.4 Million
Q1 2024

May 07, 2024

BUY
$407.69 - $446.08 $932,794 - $1.02 Million
2,288 Added 11.94%
21,450 $8.97 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $2.08 Million - $2.49 Million
6,065 Added 46.31%
19,162 $7.8 Million
Q3 2023

Nov 03, 2023

BUY
$338.18 - $362.46 $467,702 - $501,282
1,383 Added 11.81%
13,097 $4.55 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $287,694 - $321,997
-915 Reduced 7.25%
11,714 $4.12 Million
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $51,831 - $59,127
183 Added 1.47%
12,629 $3.98 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $207,461 - $233,394
-726 Reduced 5.51%
12,446 $3.59 Million
Q3 2022

Oct 27, 2022

BUY
$273.83 - $305.53 $158,273 - $176,596
578 Added 4.59%
13,172 $3.81 Million
Q2 2022

Aug 01, 2022

SELL
$234.96 - $292.55 $730,020 - $908,952
-3,107 Reduced 19.79%
12,594 $3.55 Million
Q1 2022

May 11, 2022

BUY
$221.42 - $260.97 $334,787 - $394,586
1,512 Added 10.66%
15,701 $4.1 Million
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $335,433 - $423,437
1,895 Added 15.41%
14,189 $3.12 Million
Q3 2021

Nov 10, 2021

SELL
$181.39 - $202.99 $85,978 - $96,217
-474 Reduced 3.71%
12,294 $2.23 Million
Q2 2021

Aug 05, 2021

SELL
$187.49 - $221.1 $638,965 - $753,508
-3,408 Reduced 21.07%
12,768 $2.58 Million
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $428,117 - $499,029
2,068 Added 14.66%
16,176 $3.48 Million
Q4 2020

Feb 04, 2021

BUY
$207.01 - $276.09 $190,863 - $254,554
922 Added 6.99%
14,108 $3.33 Million
Q3 2020

Nov 10, 2020

BUY
$255.65 - $303.1 $248,491 - $294,613
972 Added 7.96%
13,186 $3.59 Million
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $73,957 - $97,022
-328 Reduced 2.62%
12,214 $3.55 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $409,928 - $508,506
2,052 Added 19.56%
12,542 $2.98 Million
Q4 2019

Feb 04, 2020

BUY
$166.71 - $223.91 $79,520 - $106,805
477 Added 4.76%
10,490 $2.3 Million
Q3 2019

Nov 08, 2019

BUY
$166.23 - $187.09 $117,524 - $132,272
707 Added 7.6%
10,013 $1.7 Million
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $52,510 - $60,728
319 Added 3.55%
9,306 $1.71 Million
Q1 2019

May 08, 2019

BUY
$163.73 - $194.7 $112,155 - $133,369
685 Added 8.25%
8,987 $1.65 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $159,657 - $202,012
1,051 Added 14.49%
8,302 $1.38 Million
Q3 2018

Nov 01, 2018

SELL
$167.73 - $192.74 $19,792 - $22,743
-118 Reduced 1.6%
7,251 $1.4 Million
Q2 2018

Aug 08, 2018

SELL
$145.72 - $169.96 $191,621 - $223,497
-1,315 Reduced 15.14%
7,369 $1.25 Million
Q1 2018

May 08, 2018

BUY
$151.6 - $177.13 $253,020 - $295,629
1,669 Added 23.79%
8,684 $1.42 Million
Q4 2017

Feb 02, 2018

SELL
$137.28 - $155.55 $24,984 - $28,310
-182 Reduced 2.53%
7,015 $1.05 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $1.07 Million - $1.17 Million
7,197
7,197 $1.09 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.